HOME >> MEDICINE >> NEWS
Is society losing control of the medical research agenda?

Is society losing control of the medical research agenda? ask experts in a study published online by the BMJ today (17 March 2006) .

Medical research depends on funding from the private sector, in particular from biotechnology and drug companies, but this funding may lead to conflicts of interest about the results of medical research.

To measure the potential impact of public funding compared to industry funding, researchers analysed the affiliations of authors and the funding sources of the most frequently cited medical research papers from 1994 to 2003. Top-cited papers have a major impact on scientific thinking.

Of the 289 most frequently cited articles, most had at least one author with a university (76%) or hospital (57%) affiliation.

Government or public funding was most common (60% of articles), followed by industry (36%). However, the proportion of articles funded by industry increased over the decade and by 2001, more than 50% of funding came from industry, surpassing funding from government or public sources.

Sixty five of the 77 top-cited randomised controlled trials received funding from industry, whereas government and public sources funded only 32 trials. The proportion of trials funded by industry also increased significantly over time. Eighteen of the 32 most cited trials published after 1999 were funded by industry alone.

Participation of academics in influential medical research has remained strong, despite the perceived crisis in academic medicine, say the authors. Yet industry funds an increasing proportion of this research, especially randomised controlled trials, most of which are now funded exclusively by industry.

They suggest that the role of industry should be scrutinised further. They also believe that medical research should reflect public needs more closely and the efforts of all those involved (government, industry, and academia) should be better coordinated.


'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-207-383-6529
BMJ-British Medical Journal
16-Mar-2006


Page: 1

Related medicine news :

1. Brain research poised to dramatically advance global society
2. Advances in brain research poised to dramatically change society
3. University of Alberta hosts international conference on women in the knowledge economy and society
4. Civil society movement calls for transparency in the WHO director-general elections
5. Medical education must adapt to societys changing attitudes
6. Lung diseases represent major costs for society
7. Noisy classroom? Avoid sound-amplification systems, scientific society says
8. Medical society hosts simulation training to help reduce medical complications
9. Heart rhythm society issues draft recommendations on performance policies for pacemakers and ICDs
10. Autism has high costs to US society
11. Value of IVF children to society outweighs their cost to healthcare systems

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: society losing control the medical research agenda

(Date:8/1/2015)... (PRWEB) , ... August 01, 2015 , ... ... Partners I, L.P. (“GPP”) portfolio company has acquired Premier Physical Therapy & Wellness ... into its portfolio of state-of-the-art clinics. , “Our acquisition of Premier Physical Therapy ...
(Date:8/1/2015)... ... August 01, 2015 , ... Lume Wellness creators Alex, Robert, and Sam have ... the Apple AppStore. , The app is designed to track various metrics of ... tool to view personal health and use this information for positive behavior modification. Lume ...
(Date:8/1/2015)... ... ... “ reTXT ” was featured on NewsWatch as part of its monthly AppWatch, ... iOS, Android, and Windows. Joe Toohey, the host of AppWatch and technology expert, conducted ... any message including ones already sent. , While text messaging has more features than ...
(Date:7/31/2015)... ... 31, 2015 , ... That’s right, the STASH awards have ... The Significant Technological Achievements in Secretive Horticulture (or STASH) Awards, featured in High ... that have stood the test of time. These include lighting products, organic and ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... When the ... stuff, Super-Sod debuted their new type of sod called Leisure Time(TM) zoysia . ... in process. , To commemorate introduction of this new type of sod, Super-Sod is ...
Breaking Medicine News(10 mins):Health News:Professional Physical Therapy Now Largest Outpatient Physical Therapy Provider in Northeast With Acquisition of Premier Physical Therapy & Wellness 2Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2
(Date:7/30/2015)... CHENGDU, China , July 30, 2015 ... "Company"), a pharmaceutical company that specializes in the patented ... active pharmaceutical ingredients (API), provided updates regarding the notice ... MKT LLC (the "Exchange") indicating that the Company was ... set forth in Sections 134 and 1101 of the ...
(Date:7/30/2015)... , July 30, 2015 Eisai Inc. announced ... the United States , European Union and ... and MHLW, respectively) for eribulin, for the treatment of ... received prior chemotherapy for advanced or metastatic disease. ... from a pivotal global Phase 3 clinical trial (Study ...
(Date:7/30/2015)... , July 30, 2015 ... latest report titled, "Continuous Glucose Monitoring Systems Market: Global ... to the report, the global continuous glucose monitoring systems ... and is expected to reach US$ 788.4 Mn by ... period, 2015 to 2020. Global continuous glucose ...
Breaking Medicine Technology:TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4
Cached News: